LEO Pharma and Bayer have announced the achievement of the relevant closing conditions to allow the transfer of Bayer's ...
Omada Health has announced a $73 million round of funding led by Wellington Management Company LLP. Wellington...
RaySearch has announced the release of RayStation® 9A*, the latest version of the innovative radiation therapy treat...
The Pancreatic Cancer Action Network (PanCAN), dedicated to fighting the world's toughest cancer has announced the recip...
Ernst & Young (EY) honoured Nephron Pharmaceuticals President and CEO Lou Kennedy as Health Care...
Khiron Life Sciences Corp., a cannabis company with core operations in Latin America, applauds the EU-Mercosur Trad...
Vaxess Technologies, a biotechnology company redefining drug delivery with the silk-powered MIMIX smart release patch ha...
WHO has announced the appointment of Professor Keizo Takemi as WHO Goodwill Ambassador for Universal Health Coverage. P...
Sartorius Stedim Biotech (SSB), a leading international partner of the biopharmaceutical industry has recently laun...
Roche has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use...
Pfizer has announced the election of Dr. Scott Gottlieb to its Board of Directors, effective immediately. Dr. Gottl...
The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the U.S. Food and Drug Administration (FDA) ...
Thermo Fisher Scientific has developed a new line of next-generation open air orbital shakers to offer unmatched reliabi...
CarThera, a French company that designs and develops innovative ultrasound-based medical devices to treat brain disorder...
Concept Life Sciences, a knowledge-based provider of integrated discovery, development and analytical services, on 18 Ju...
AbbVie and Allergan have announced that the companies have entered into a definitive transaction agreement und...
The U.S. Food and Drug Administration has approved Dupixent (dupilumab) to treat adults with nasal polyps (growths on th...
A large clinical trial to assess treatments for preventing people at high risk from developing multidrug-resistant tuber...
